Request for Covid-19 Impact Assessment of this Report

Diagnostic and Biotech

Europe Biosimilars Market Report 2016

  • QYR711799
  • 122 Pages
  • October 2016
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Biosimilars

Revenue, means the sales value of Biosimilars

This report studies sales (consumption) of Biosimilars in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

Roche

Amgen

AbbVie

Sanofi-Aventis

Johnson & Johnson

Pfizer

Novo Nordisk

Eli Lilly

Novartis

Merck

3sbio

Changchun High Tech

CP Guojian

Biotech

Gelgen

Innovent

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Biosimilars in these countries, from 2011 to 2021 (forecast), like

Germany

France

UK

Russia

Italy

Spain

Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

Antibody

Hormone

Growth Factors

Others

Split by application, this report focuses on sales, market share and growth rate of Biosimilars in each application, can be divided into

Tumor

Diabetes

Cardiovascular

Hemophilia

Others

Table of Contents

Europe Biosimilars Market Report 2016

1 Biosimilars Overview

1.1 Product Overview and Scope of Biosimilars

1.2 Classification of Biosimilars

1.2.1 Antibody

1.2.2 Hormone

1.2.3 Growth Factors

1.2.4 Others

1.3 Application of Biosimilars

1.3.1 Tumor

1.3.2 Diabetes

1.3.3 Cardiovascular

1.3.4 Hemophilia

1.3.5 Others

1.4 Biosimilars Market by Countries

1.4.1 Germany Status and Prospect (2011-2021)

1.4.2 France Status and Prospect (2011-2021)

1.4.3 UK Status and Prospect (2011-2021)

1.4.4 Russia Status and Prospect (2011-2021)

1.4.5 Italy Status and Prospect (2011-2021)

1.4.6 Spain Status and Prospect (2011-2021)

1.4.7 Benelux Status and Prospect (2011-2021)

1.5 Europe Market Size (Value and Volume) of Biosimilars (2011-2021)

1.5.1 Europe Biosimilars Sales and Growth Rate (2011-2021)

1.5.2 Europe Biosimilars Revenue and Growth Rate (2011-2021)

2 Europe Biosimilars by Manufacturers, Type and Application

2.1 Europe Biosimilars Market Competition by Manufacturers

2.1.1 Europe Biosimilars Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Biosimilars Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Biosimilars (Volume and Value) by Type

2.2.1 Europe Biosimilars Sales and Market Share by Type (2011-2016)

2.2.2 Europe Biosimilars Revenue and Market Share by Type (2011-2016)

2.3 Europe Biosimilars (Volume and Value) by Countries

2.3.1 Europe Biosimilars Sales and Market Share by Countries (2011-2016)

2.3.2 Europe Biosimilars Revenue and Market Share by Countries (2011-2016)

2.4 Europe Biosimilars (Volume) by Application

3 Germany Biosimilars (Volume, Value and Sales Price)

3.1 Germany Biosimilars Sales and Value (2011-2016)

3.1.1 Germany Biosimilars Sales and Growth Rate (2011-2016)

3.1.2 Germany Biosimilars Revenue and Growth Rate (2011-2016)

3.1.3 Germany Biosimilars Sales Price Trend (2011-2016)

3.2 Germany Biosimilars Sales and Market Share by Manufacturers

3.3 Germany Biosimilars Sales and Market Share by Type

3.4 Germany Biosimilars Sales and Market Share by Application

4 France Biosimilars (Volume, Value and Sales Price)

4.1 France Biosimilars Sales and Value (2011-2016)

4.1.1 France Biosimilars Sales and Growth Rate (2011-2016)

4.1.2 France Biosimilars Revenue and Growth Rate (2011-2016)

4.1.4 France Biosimilars Sales Price Trend (2011-2016)

4.2 France Biosimilars Sales and Market Share by Manufacturers

4.3 France Biosimilars Sales and Market Share by Type

4.4 France Biosimilars Sales and Market Share by Application

5 UK Biosimilars (Volume, Value and Sales Price)

5.1 UK Biosimilars Sales and Value (2011-2016)

5.1.1 UK Biosimilars Sales and Growth Rate (2011-2016)

5.1.2 UK Biosimilars Revenue and Growth Rate (2011-2016)

5.1.5 UK Biosimilars Sales Price Trend (2011-2016)

5.2 UK Biosimilars Sales and Market Share by Manufacturers

5.3 UK Biosimilars Sales and Market Share by Type

5.4 UK Biosimilars Sales and Market Share by Application

6 Russia Biosimilars (Volume, Value and Sales Price)

6.1 Russia Biosimilars Sales and Value (2011-2016)

6.1.1 Russia Biosimilars Sales and Growth Rate (2011-2016)

6.1.2 Russia Biosimilars Revenue and Growth Rate (2011-2016)

6.1.6 Russia Biosimilars Sales Price Trend (2011-2016)

6.2 Russia Biosimilars Sales and Market Share by Manufacturers

6.3 Russia Biosimilars Sales and Market Share by Type

6.4 Russia Biosimilars Sales and Market Share by Application

7 Italy Biosimilars (Volume, Value and Sales Price)

7.1 Italy Biosimilars Sales and Value (2011-2016)

7.1.1 Italy Biosimilars Sales and Growth Rate (2011-2016)

7.1.2 Italy Biosimilars Revenue and Growth Rate (2011-2016)

7.1.7 Italy Biosimilars Sales Price Trend (2011-2016)

7.2 Italy Biosimilars Sales and Market Share by Manufacturers

7.3 Italy Biosimilars Sales and Market Share by Type

7.4 Italy Biosimilars Sales and Market Share by Application

8 Spain Biosimilars (Volume, Value and Sales Price)

8.1 Spain Biosimilars Sales and Value (2011-2016)

8.1.1 Spain Biosimilars Sales and Growth Rate (2011-2016)

8.1.2 Spain Biosimilars Revenue and Growth Rate (2011-2016)

8.1.8 Spain Biosimilars Sales Price Trend (2011-2016)

8.2 Spain Biosimilars Sales and Market Share by Manufacturers

8.3 Spain Biosimilars Sales and Market Share by Type

8.4 Spain Biosimilars Sales and Market Share by Application

9 Benelux Biosimilars (Volume, Value and Sales Price)

9.1 Benelux Biosimilars Sales and Value (2011-2016)

9.1.1 Benelux Biosimilars Sales and Growth Rate (2011-2016)

9.1.2 Benelux Biosimilars Revenue and Growth Rate (2011-2016)

9.1.9 Benelux Biosimilars Sales Price Trend (2011-2016)

9.2 Benelux Biosimilars Sales and Market Share by Manufacturers

9.3 Benelux Biosimilars Sales and Market Share by Type

9.4 Benelux Biosimilars Sales and Market Share by Application

10 Europe Biosimilars Manufacturers Analysis

10.1 Roche

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Biosimilars Product Type, Application and Specification

10.1.2.1 Type I

10.1.2.2 Type II

10.1.3 Roche Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

10.1.4 Main Business/Business Overview

10.2 Amgen

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Biosimilars Product Type, Application and Specification

10.2.2.1 Type I

10.2.2.2 Type II

10.2.3 Amgen Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

10.2.4 Main Business/Business Overview

10.3 AbbVie

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Biosimilars Product Type, Application and Specification

10.3.2.1 Type I

10.3.2.2 Type II

10.3.3 AbbVie Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

10.3.4 Main Business/Business Overview

10.4 Sanofi-Aventis

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Biosimilars Product Type, Application and Specification

10.4.2.1 Type I

10.4.2.2 Type II

10.4.3 Sanofi-Aventis Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

10.4.4 Main Business/Business Overview

10.5 Johnson & Johnson

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Biosimilars Product Type, Application and Specification

10.5.2.1 Type I

10.5.2.2 Type II

10.5.3 Johnson & Johnson Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

10.5.4 Main Business/Business Overview

10.6 Pfizer

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 Biosimilars Product Type, Application and Specification

10.6.2.1 Type I

10.6.2.2 Type II

10.6.3 Pfizer Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

10.6.4 Main Business/Business Overview

10.7 Novo Nordisk

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 Biosimilars Product Type, Application and Specification

10.7.2.1 Type I

10.7.2.2 Type II

10.7.3 Novo Nordisk Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

10.7.4 Main Business/Business Overview

10.8 Eli Lilly

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 Biosimilars Product Type, Application and Specification

10.8.2.1 Type I

10.8.2.2 Type II

10.8.3 Eli Lilly Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

10.8.4 Main Business/Business Overview

10.9 Novartis

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 Biosimilars Product Type, Application and Specification

10.9.2.1 Type I

10.9.2.2 Type II

10.9.3 Novartis Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

10.9.4 Main Business/Business Overview

10.10 Merck

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 Biosimilars Product Type, Application and Specification

10.10.2.1 Type I

10.10.2.2 Type II

10.10.3 Merck Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

10.10.4 Main Business/Business Overview

10.11 3sbio

10.12 Changchun High Tech

10.13 CP Guojian

10.14 Biotech

10.15 Gelgen

10.16 Innovent

11 Biosimilars Manufacturing Cost Analysis

11.1 Biosimilars Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Biosimilars

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Biosimilars Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Biosimilars Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe Biosimilars Market Forecast (2016-2021)

14.1 Germany Biosimilars Sales Forecast (2016-2021)

14.2 France Biosimilars Sales Forecast (2016-2021)

14.3 UK Biosimilars Sales Forecast (2016-2021)

14.4 Russia Biosimilars Sales Forecast (2016-2021)

14.5 Italy Biosimilars Sales Forecast (2016-2021)

14.6 Spain Biosimilars Sales Forecast (2016-2021)

14.7 Benelux Biosimilars Sales Forecast (2016-2021)

14.8 Europe Biosimilars Sales Forecast by Type (2016-2021)

14.9 Europe Biosimilars Sales Forecast by Application (2016-2021)

15 Research Findings and Conclusion

16 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Biosimilars

Table Classification of Biosimilars

Figure Europe Sales Market Share of Biosimilars by Type in 2015

Figure Antibody Picture

Figure Hormone Picture

Figure Growth Factors Picture

Figure Others Picture

Table Application of Biosimilars

Figure Europe Sales Market Share of Biosimilars by Application in 2015

Figure Tumor Examples

Figure Diabetes Examples

Figure Cardiovascular Examples

Figure Hemophilia Examples

Figure Others Examples

Figure Germany Biosimilars Revenue and Growth Rate (2011-2021)

Figure France Biosimilars Revenue and Growth Rate (2011-2021)

Figure UK Biosimilars Revenue and Growth Rate (2011-2021)

Figure Russia Biosimilars Revenue and Growth Rate (2011-2021)

Figure Italy Biosimilars Revenue and Growth Rate (2011-2021)

Figure Spain Biosimilars Revenue and Growth Rate (2011-2021)

Figure Benelux Biosimilars Revenue and Growth Rate (2011-2021)

Figure Europe Biosimilars Sales and Growth Rate (2011-2021)

Figure Europe Biosimilars Revenue and Growth Rate (2011-2021)

Table Europe Biosimilars Sales of Key Manufacturers (2015 and 2016)

Table Europe Biosimilars Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Biosimilars Sales Share by Manufacturers

Figure 2016 Biosimilars Sales Share by Manufacturers

Table Europe Biosimilars Revenue by Manufacturers (2015 and 2016)

Table Europe Biosimilars Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Biosimilars Revenue Share by Manufacturers

Table 2016 Europe Biosimilars Revenue Share by Manufacturers

Table Europe Biosimilars Sales and Market Share by Type (2011-2016)

Table Europe Biosimilars Sales Share by Type (2011-2016)

Figure Sales Market Share of Biosimilars by Type (2011-2016)

Figure Europe Biosimilars Sales Growth Rate by Type (2011-2016)

Table Europe Biosimilars Revenue and Market Share by Type (2011-2016)

Table Europe Biosimilars Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Biosimilars by Type (2011-2016)

Figure Europe Biosimilars Revenue Growth Rate by Type (2011-2016)

Table Europe Biosimilars Sales and Market Share by Countries (2011-2016)

Table Europe Biosimilars Sales Share by Countries (2011-2016)

Figure Sales Market Share of Biosimilars by Countries (2011-2016)

Table Europe Biosimilars Revenue and Market Share by Countries (2011-2016)

Table Europe Biosimilars Revenue Share by Countries (2011-2016)

Figure Revenue Market Share of Biosimilars by Countries (2011-2016)

Table Europe Biosimilars Sales and Market Share by Application (2011-2016)

Table Europe Biosimilars Sales Share by Application (2011-2016)

Figure Sales Market Share of Biosimilars by Application (2011-2016)

Figure Germany Biosimilars Sales and Growth Rate (2011-2016)

Figure Germany Biosimilars Revenue and Growth Rate (2011-2016)

Figure Germany Biosimilars Sales Price Trend (2011-2016)

Table Germany Biosimilars Sales by Manufacturers (2015 and 2016)

Table Germany Biosimilars Market Share by Manufacturers (2015 and 2016)

Table Germany Biosimilars Sales by Type (2015 and 2016)

Table Germany Biosimilars Market Share by Type (2015 and 2016)

Table Germany Biosimilars Sales by Application (2015 and 2016)

Table Germany Biosimilars Market Share by Application (2015 and 2016)

Figure France Biosimilars Sales and Growth Rate (2011-2016)

Figure France Biosimilars Revenue and Growth Rate (2011-2016)

Figure France Biosimilars Sales Price Trend (2011-2016)

Table France Biosimilars Sales by Manufacturers (2015 and 2016)

Table France Biosimilars Market Share by Manufacturers (2015 and 2016)

Table France Biosimilars Sales by Type (2015 and 2016)

Table France Biosimilars Market Share by Type (2015 and 2016)

Table France Biosimilars Sales by Application (2015 and 2016)

Table France Biosimilars Market Share by Application (2015 and 2016)

Figure UK Biosimilars Sales and Growth Rate (2011-2016)

Figure UK Biosimilars Revenue and Growth Rate (2011-2016)

Figure UK Biosimilars Sales Price Trend (2011-2016)

Table UK Biosimilars Sales by Manufacturers (2015 and 2016)

Table UK Biosimilars Market Share by Manufacturers (2015 and 2016)

Table UK Biosimilars Sales by Type (2015 and 2016)

Table UK Biosimilars Market Share by Type (2015 and 2016)

Table UK Biosimilars Sales by Application (2015 and 2016)

Table UK Biosimilars Market Share by Application (2015 and 2016)

Figure Russia Biosimilars Sales and Growth Rate (2011-2016)

Figure Russia Biosimilars Revenue and Growth Rate (2011-2016)

Figure Russia Biosimilars Sales Price Trend (2011-2016)

Table Russia Biosimilars Sales by Manufacturers (2015 and 2016)

Table Russia Biosimilars Market Share by Manufacturers (2015 and 2016)

Table Russia Biosimilars Sales by Type (2015 and 2016)

Table Russia Biosimilars Market Share by Type (2015 and 2016)

Table Russia Biosimilars Sales by Application (2015 and 2016)

Table Russia Biosimilars Market Share by Application (2015 and 2016)

Figure Italy Biosimilars Sales and Growth Rate (2011-2016)

Figure Italy Biosimilars Revenue and Growth Rate (2011-2016)

Figure Italy Biosimilars Sales Price Trend (2011-2016)

Table Italy Biosimilars Sales by Manufacturers (2015 and 2016)

Table Italy Biosimilars Market Share by Manufacturers (2015 and 2016)

Table Italy Biosimilars Sales by Type (2015 and 2016)

Table Italy Biosimilars Market Share by Type (2015 and 2016)

Table Italy Biosimilars Sales by Application (2015 and 2016)

Table Italy Biosimilars Market Share by Application (2015 and 2016)

Figure Spain Biosimilars Sales and Growth Rate (2011-2016)

Figure Spain Biosimilars Revenue and Growth Rate (2011-2016)

Figure Spain Biosimilars Sales Price Trend (2011-2016)

Table Spain Biosimilars Sales by Manufacturers (2015 and 2016)

Table Spain Biosimilars Market Share by Manufacturers (2015 and 2016)

Table Spain Biosimilars Sales by Type (2015 and 2016)

Table Spain Biosimilars Market Share by Type (2015 and 2016)

Table Spain Biosimilars Sales by Application (2015 and 2016)

Table Spain Biosimilars Market Share by Application (2015 and 2016)

Figure Benelux Biosimilars Sales and Growth Rate (2011-2016)

Figure Benelux Biosimilars Revenue and Growth Rate (2011-2016)

Figure Benelux Biosimilars Sales Price Trend (2011-2016)

Table Benelux Biosimilars Sales by Manufacturers (2015 and 2016)

Table Benelux Biosimilars Market Share by Manufacturers (2015 and 2016)

Table Benelux Biosimilars Sales by Type (2015 and 2016)

Table Benelux Biosimilars Market Share by Type (2015 and 2016)

Table Benelux Biosimilars Sales by Application (2015 and 2016)

Table Benelux Biosimilars Market Share by Application (2015 and 2016)

Table Biosimilars Basic Information List

Table Roche Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Roche Biosimilars Sales Market Share (2011-2016)

Table Amgen Basic Information List

Table Amgen Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Table Amgen Biosimilars Sales Market Share (2011-2016)

Table AbbVie Basic Information List

Table AbbVie Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Table AbbVie Biosimilars Sales Market Share (2011-2016)

Table Sanofi-Aventis Basic Information List

Table Sanofi-Aventis Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sanofi-Aventis Biosimilars Sales Market Share (2011-2016)

Table Johnson & Johnson Basic Information List

Table Johnson & Johnson Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Table Johnson & Johnson Biosimilars Sales Market Share (2011-2016)

Table Pfizer Basic Information List

Table Pfizer Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Table Pfizer Biosimilars Sales Market Share (2011-2016)

Table Novo Nordisk Basic Information List

Table Novo Nordisk Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novo Nordisk Biosimilars Sales Market Share (2011-2016)

Table Eli Lilly Basic Information List

Table Eli Lilly Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Table Eli Lilly Biosimilars Sales Market Share (2011-2016)

Table Novartis Basic Information List

Table Novartis Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novartis Biosimilars Sales Market Share (2011-2016)

Table Merck Basic Information List

Table Merck Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck Biosimilars Sales Market Share (2011-2016)

Table 3sbio Basic Information List

Table 3sbio Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Table 3sbio Biosimilars Sales Market Share (2011-2016)

Table Changchun High Tech Basic Information List

Table Changchun High Tech Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Table Changchun High Tech Biosimilars Sales Market Share (2011-2016)

Table CP Guojian Basic Information List

Table CP Guojian Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Table CP Guojian Biosimilars Sales Market Share (2011-2016)

Table Biotech Basic Information List

Table Biotech Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Table Biotech Biosimilars Sales Market Share (2011-2016)

Table Gelgen Basic Information List

Table Gelgen Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Table Gelgen Biosimilars Sales Market Share (2011-2016)

Table Innovent Basic Information List

Table Innovent Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Table Innovent Biosimilars Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Biosimilars

Figure Manufacturing Process Analysis of Biosimilars

Figure Biosimilars Industrial Chain Analysis

Table Raw Materials Sources of Biosimilars Major Manufacturers in 2015

Table Major Buyers of Biosimilars

Table Distributors/Traders List

Figure Germany Biosimilars Sales and Growth Rate Forecast (2016-2021)

Figure Germany Biosimilars Revenue and Growth Rate Forecast (2016-2021)

Figure France Biosimilars Sales and Growth Rate Forecast (2016-2021)

Figure France Biosimilars Revenue and Growth Rate Forecast (2016-2021)

Figure UK Biosimilars Sales and Growth Rate Forecast (2016-2021)

Figure UK Biosimilars Revenue and Growth Rate Forecast (2016-2021)

Figure Russia Biosimilars Sales and Growth Rate Forecast (2016-2021)

Figure Russia Biosimilars Revenue and Growth Rate Forecast (2016-2021)

Figure Italy Biosimilars Sales and Growth Rate Forecast (2016-2021)

Figure Italy Biosimilars Revenue and Growth Rate Forecast (2016-2021)

Figure Spain Biosimilars Sales and Growth Rate Forecast (2016-2021)

Figure Spain Biosimilars Revenue and Growth Rate Forecast (2016-2021)

Figure Benelux Biosimilars Sales and Growth Rate Forecast (2016-2021)

Figure Benelux Biosimilars Revenue and Growth Rate Forecast (2016-2021)

Table Europe Biosimilars Sales Forecast by Type (2016-2021)

Table Europe Biosimilars Sales Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Biomaterials Market by Type (Metallic, Polymeric, Ceramic and Natural) and Application (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic, Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders and Drug-Delivery Systems) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...

  • Publish Date: September 1, 2016
  • $5370
DNA Sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017 - 2025

The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...

  • Publish Date: May 24, 2017
  • $5370